It is often linked to autoimmune activity and can lead to widespread changes in physical, digestive, and cognitive processes
The most frequently reported mood-related effects of levetiracetam include: Irritability Increased anger or frustration Anxiety or feeling on edge Sadness or low mood Emotional sensitivity Trouble managing stress Feeling tired or mentally drained These effects may appear shortly after starting the medication or after a dose increase
It affects more than one billion people worldwide and is associated with an estimated 3.7 million deaths from noncommunicable diseases in 2024 alone
LLY's infectious disease deals offer long-term upside, notably with amezosvatein showing superior tolerability to Shingrix, but meaningful revenues are unlikely before 2030
Trends Endocrinol Metab 29(4):218237 Miras AD et al (2019) Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial
[DOI] [PMC free article] [PubMed] [Google Scholar] 899
